Pettyjohn Wood & White’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $486K | Sell |
17,313
-250
| -1% | -$6.66K | 0.08% | 138 |
|
|
2025
Q4 | $437K | Sell |
17,563
-5,528
| -24% | -$139K | 0.07% | 144 |
|
|
2025
Q3 | $588K | Sell |
23,091
-4,700
| -17% | -$116K | 0.1% | 121 |
|
|
2025
Q2 | $674K | Sell |
27,791
-875
| -3% | -$20.4K | 0.12% | 109 |
|
|
2025
Q1 | $726K | Sell |
28,666
-5,100
| -15% | -$133K | 0.14% | 102 |
|
|
2024
Q4 | $896K | Sell |
33,766
-11,049
| -25% | -$300K | 0.16% | 92 |
|
|
2024
Q3 | $1.3M | Sell |
44,815
-2,590
| -5% | -$75.6K | 0.24% | 80 |
|
|
2024
Q2 | $1.33M | Sell |
47,405
-1,750
| -4% | -$48.2K | 0.26% | 74 |
|
|
2024
Q1 | $1.36M | Sell |
49,155
-1,800
| -4% | -$49.9K | 0.27% | 73 |
|
|
2023
Q4 | $1.47M | Sell |
50,955
-8,692
| -15% | -$263K | 0.32% | 70 |
|
|
2023
Q3 | $1.98M | Sell |
59,647
-3,083
| -5% | -$109K | 0.47% | 53 |
|
|
2023
Q2 | $2.3M | Buy |
62,730
+1,450
| +2% | +$56.4K | 0.53% | 50 |
|
|
2023
Q1 | $2.5M | Sell |
61,280
-75
| -0.1% | -$3.24K | 0.61% | 48 |
|
|
2022
Q4 | $3.14M | Sell |
61,355
-52
| -0.1% | -$2.49K | 0.78% | 38 |
|
|
2022
Q3 | $2.69M | Buy |
61,407
+1,325
| +2% | +$64.4K | 0.72% | 45 |
|
|
2022
Q2 | $3.15M | Buy |
60,082
+5,311
| +10% | +$271K | 0.75% | 43 |
|
|
2022
Q1 | $2.84M | Buy |
54,771
+2,710
| +5% | +$141K | 0.61% | 50 |
|
|
2021
Q4 | $3.07M | Sell |
52,061
-1,837
| -3% | -$91K | 0.63% | 48 |
|
|
2021
Q3 | $2.32M | Sell |
53,898
-12,489
| -19% | -$553K | 0.51% | 54 |
|
|
2021
Q2 | $2.6M | Sell |
66,387
-8,640
| -12% | -$336K | 0.58% | 51 |
|
|
2021
Q1 | $2.72M | Sell |
75,027
-9,777
| -12% | -$347K | 0.64% | 48 |
|
|
2020
Q4 | $3.12M | Sell |
84,804
-4,379
| -5% | -$161K | 0.8% | 42 |
|
|
2020
Q3 | $3.1M | Buy |
89,183
+316
| +0.4% | +$11.1K | 0.91% | 39 |
|
|
2020
Q2 | $2.76M | Buy |
88,867
+2,582
| +3% | +$87.7K | 0.88% | 40 |
|
|
2020
Q1 | $2.67M | Buy |
86,285
+106
| +0.1% | +$3.61K | 1% | 36 |
|
|
2019
Q4 | $3.2M | Sell |
86,179
-1,186
| -1% | -$42.2K | 0.92% | 39 |
|
|
2019
Q3 | $2.98M | Sell |
87,365
-843
| -1% | -$30.7K | 0.9% | 39 |
|
|
2019
Q2 | $3.63M | Buy |
88,208
+1,143
| +1% | +$45.4K | 1.12% | 35 |
|
|
2019
Q1 | $3.51M | Buy |
87,065
+2,022
| +2% | +$81K | 1.14% | 35 |
|
|
2018
Q4 | $3.52M | Buy |
85,043
+2,419
| +3% | +$100K | 1.29% | 31 |
|
|
2018
Q3 | $3.46M | Sell |
82,624
-1,834
| -2% | -$70.6K | 1.12% | 35 |
|
|
2018
Q2 | $2.91M | Buy |
84,458
+4,806
| +6% | +$164K | 1.02% | 36 |
|
|
2018
Q1 | $2.68M | Buy |
79,652
+1,297
| +2% | +$44.6K | 0.97% | 36 |
|
|
2017
Q4 | $2.69M | Sell |
78,355
-1,200
| -2% | -$40.9K | 0.97% | 35 |
|
|
2017
Q3 | $2.69M | Buy |
79,555
+155
| +0.2% | +$4.98K | 1% | 37 |
|
|
2017
Q2 | $2.53M | Sell |
79,400
-28
| -0% | -$883 | 0.94% | 40 |
|
|
2017
Q1 | $2.58M | Sell |
79,428
-327
| -0.4% | -$10.3K | 0.96% | 40 |
|
|
2016
Q4 | $2.46M | Buy |
79,755
+105
| +0.1% | +$3.21K | 0.95% | 37 |
|
|
2016
Q3 | $2.56M | Sell |
79,650
-1,876
| -2% | -$62.7K | 1.22% | 29 |
|
|
2016
Q2 | $2.72M | Sell |
81,526
-1,444
| -2% | -$46.1K | 1.08% | 34 |
|
|
2016
Q1 | $2.33M | Sell |
82,970
-5,480
| -6% | -$157K | 0.95% | 37 |
|
|
2015
Q4 | $2.71M | Buy |
88,450
+2,319
| +3% | +$73K | 1.15% | 31 |
|
|
2015
Q3 | $2.57M | Sell |
86,131
-1,370
| -2% | -$43.9K | 1.18% | 30 |
|
|
2015
Q2 | $2.78M | Sell |
87,501
-945
| -1% | -$30.8K | 1.17% | 29 |
|
|
2015
Q1 | $2.92M | Sell |
88,446
-501
| -0.6% | -$15.9K | 1.21% | 28 |
|
|
2014
Q4 | $2.63M | Buy |
88,947
+1,017
| +1% | +$29.2K | 1.09% | 33 |
|
|
2014
Q3 | $2.47M | Buy |
87,930
+685
| +0.8% | +$19.2K | 1.07% | 34 |
|
|
2014
Q2 | $2.46M | Buy |
87,245
+2,820
| +3% | +$80.4K | 1.07% | 33 |
|
|
2014
Q1 | $2.57M | Buy |
84,425
+63,093
| +296% | +$1.88M | 1.18% | 27 |
|
|
2013
Q4 | $620K | Buy |
21,332
+632
| +3% | +$18.4K | 0.36% | 78 |
|
|
2013
Q3 | $564K | Sell |
20,700
-280
| -1% | -$7.62K | 0.35% | 79 |
|
|
2013
Q2 | $558K | Buy |
+20,980
| New | +$580K | 0.35% | 77 |
|
Other funds holding PFE
VCM
VPM
Pettyjohn Wood & White's PFE Position: Q1 2026 in Review
Pettyjohn Wood & White reduced its Pfizer (PFE) stake by 1.4% in Q1 2026, selling an estimated $6.66K and leaving 17,313 shares worth $486K. The position accounts for 0.08% of the portfolio, ranked #138.
Pettyjohn Wood & White first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.63M in Q2 2019. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Pettyjohn Wood & White held 17,313 shares of Pfizer worth $486K as of Q1 2026.
- Pettyjohn Wood & White sold 250 Pfizer shares in Q1 2026, an estimated $6.66K.
- Pfizer made up 0.08% of Pettyjohn Wood & White's portfolio in Q1 2026, its #138 holding.
- Pettyjohn Wood & White first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Pettyjohn Wood & White's Pfizer position peaked at $3.63M in Q2 2019.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Pettyjohn Wood & White's 13F filing for Q1 2026, filed 15 May 2026.